The Enabling Technologies Consortium™ is comprised of pharmaceutical and biotechnology companies collaborating on issues related to pharmaceutical chemistry, manufacturing, and control with the goal of identifying, evaluating, developing, and improving scientific tools and techniques that support the efficient development and manufacturing of pharmaceuticals.
ETC has released a Request for Information for development of a next generation automated solubility platform. Questions should be submitted by January 31, 2018. Responses are due February 28, 2018. Read the RFI and submit your response.
The Enabling Technologies Consortium (ETC): Fostering Precompetitive Collaborations on New Enabling Technologies for Pharmaceutical Research and Development, authored by the Enabling Technologies Consortium™ Board of Directors, and The Pharmaceutical Drying Unit Operation: An Industry Perspective on Advancing the Science and Development Approach for Scale-up and Technology Transfer, authored by the Drying Working Group, have been published in Organic Process Research & Development.
If you are interested in joining our Consortium or learning more, please contact us.
ETC™ regularly issues Requests for Information to solicit interest in collaborating on high-value opportunities to deliver innovative technologies with a compelling business case. See our current opportunities.